Last update Dec. 28, 2021
Very Low Risk
It is a derivative of isoproterenol with beta-1 agonist sympathomimetic action that is used to treat cardiac decompensation in patients with organic heart disease or from cardiac surgery. Administration by intravenous infusion.
Since the last update we have not found any published data on its excretion in breast milk.
Its very short half-life (elimination half-life: 2 minutes) make it highly unlikely that significant quantities will pass into breast milk. (Kearney 2018)
Its null oral bioavailability prevents the pasage to the infant plasma from ingested breast milk, except in premature infants and in the immediate neonatal period in which there may be greater intestinal permeability. (Kearney 2018)
Expert authors consider the use of this medication to be probably compatible during breastfeeding. (Hale, Kearney 2018, Briggs 2015)
We do not have alternatives for Dobutamine Hydrochloride since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM